Cardio Diagnostics Holdings Inc (CDIO) Stock: A Closer Look

At the time of writing, Cardio Diagnostics Holdings Inc [CDIO] stock is trading at $0.45, up 6.15%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CDIO shares have gain 0.87% over the last week, with a monthly amount drifted -51.44%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

For the past year, the stock price of Cardio Diagnostics Holdings Inc fluctuated between $0.19 and $2.05. Cardio Diagnostics Holdings Inc [NASDAQ: CDIO] shares were valued at $0.45 at the most recent close of the market.

Analyzing the CDIO fundamentals

According to Cardio Diagnostics Holdings Inc [NASDAQ:CDIO], the company’s sales were 0.04M for trailing twelve months, which represents an -34.40% plunge. Gross Profit Margin for this corporation currently stands at -3.06% with Operating Profit Margin at -235.13%, Pretax Profit Margin comes in at -231.26%, and Net Profit Margin reading is -231.26%. To continue investigating profitability, this company’s Return on Assets is posted at -1.84, Equity is -2.59 and Total Capital is -2.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.2.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4239 points at the first support level, and at 0.3941 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.4718, and for the 2nd resistance point, it is at 0.4899.

Ratios To Look Out For

It is important to note that Cardio Diagnostics Holdings Inc [NASDAQ:CDIO] has a current ratio of 8.51. In addition, the Quick Ratio stands at 8.51 and the Cash Ratio stands at 6.42. Considering the valuation of this stock, the price to sales ratio is 458.84, the price to book ratio is 3.73.

Transactions by insiders

Recent insider trading involved Philibert Robert, Chief Medical Officer, that happened on Sep 06 ’24 when 34075.0 shares were purchased. Chief Technology Officer, Dogan Meeshanthini completed a deal on Sep 06 ’24 to buy 68965.0 shares. Meanwhile, Chief Executive Officer Dogan Meeshanthini bought 68965.0 shares on Sep 06 ’24.

Related Posts